Intro to Pharmacodynamics Flashcards
What is the difference between pharmacokinetics and pharmacodynamics?
Pharmacokinetics: the effect of the body on drugs; how the body absorbs, distributes, metabolizes, and eliminates drugs
Pharmacodynamics: the effect of drugs on the body; how the drug binds to drug receptors, its dose-response curve, and MOA
A specific molecule in a biological system that plays a regulatory role; it interacts with a drug and initiates the biochemical events leading to drug effects
Receptor
Component of the biologic system to which a drug binds without changing any fx
A molecule that binds to a receptor
Inert binding site
Ligand
What is a dose response curve?
Graphing the drug dose arithmetically on the x-axis with the drug effects on the y-axis creates a ____.
Graphing the logarithm of the drug dose vs. the drug effect creates a ____.
Quantitatively shows the relationship between a drug and its effect
Hyperbolic curve
Sigmoidal curve
What is the Emax?
ED50?
The maximal effect that can be produced by the drug
The dose of drug that produces 50% of its maximal effect (mean effective dose)
_____ response curves answer the question of “how much”. The magnitude of a response varies ____. Represents the ____ within a population.
A graded dose means that a slight increase of drug brings a small ____ in response.
Example?
Graded
Continuously (measured on a continuous scale)
Mean value
Increase
Heart rate
____ response curves answer the question of “does this response occur or not? And in how many?”
It requires a pre-defined response. And is used to examine the ____ of a response in a population.
Example?
Quantal
Frequency
Epileptic seizures
What is a non-cumulative quantal dose response curve?
Cumulative?
The number of individuals responding at a dose of a drug and only at that dose
Number of individuals responding at a dose of a drug and at all doses lower
ED50
TD50
LD50
How do you calculate TI?
What does TI mean?
What is the therapeutic window?
Median effective dose
Median toxic dose
Median lethal dose
Therapeutic index (TI)= TD50/ED50
Higher the TI the safer the drug
The range of doses of a drug or of its concentration in a body system that provides safe and effective therapy
What is affinity?
What is the difference between high and low affinity?
How readily and tightly the drug binds to its receptor
High affinity: good drug-receptor interaction; less drug needed for a response
Low affinity: poor drug receptor interaction; more drug needed for a response
____ is a property of a drug determined by its affinities at various binding sites.
A more selective drug would affect ____ targets over a specific concentration range.
Selectivity
Fewer
____ describes the ability of a drug to change a receptor fx and produce a physiological response upon its binding to a receptor.
____ binds to the receptor and stabilize it in a particular conformation producing a physiologic response. Have intrinsic activity.
____ binds to the receptor but does not change its fx. It prevents activation of the receptor in the presence of an agonist. NO intrinsic activity.
Intrinsic activity
Agonist
Antagonist
What are the three types of agonist drugs?
Full agonists: produce maximal pharmacological effects at full receptor occupancy
Partial agonists: produce sub-maximal pharmacological effects at full receptor occupancy (lower Emax)
Inverse agonists: produce an effect opposite a full or partial agonist
What are the three types of antagonism?
Pharmacologic: action at the same receptor as endogenous ligands or agonist drugs
Chemical: when a chemical antagonist makes the other drug unavailable (non-receptor antagonist)
Physiologic: occurs between endogenous pathways regulated by different receptors (non-receptor antagonist)
Pharmacologic antagonists are receptor antagonists. Where are the two places they bind?
A ____ makes the agonist look less potent by shifting the dose-response curve to the right.
A ____ reduces the maximal response that an agonist can produce.
Agonist site binding: reversible -> competitive antagonist; irreversible -> noncompetitive agonist site antagonist
Allosteric site binding: reversible or irreversible -> noncompetitive allosteric antagonist
Competitive antagonist
Noncompetitive antagonist